13F HOLDINGS REPORT
Kalehua Capital Management LLC
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0002106181-26-000003
Total Value
$101.1M
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Alpha Architect 1-3 Month Box Etf | 02072L565 | 230,787 | $26.6M | 26.27% |
| 2 | X4 Pharmaceuticals Inc | XFOR | 3,722,840 | $14.9M | 14.73% |
| 3 | Sionna Therapeutics Inc | SION | 197,072 | $8.1M | 8.02% |
| 4 | Relay Therapeutics Inc | RLAY | 901,457 | $7.6M | 7.54% |
| 5 | Compass Pathways Plc | CMPS | 819,692 | $5.7M | 5.59% |
| 6 | Pharvaris NV | PHVS | 198,772 | $5.5M | 5.46% |
| 7 | Septerna Inc | SEPN | 194,544 | $5.4M | 5.36% |
| 8 | Oruka Therapeutics Inc | ORKA | 118,524 | $3.6M | 3.55% |
| 9 | Inhibikase Therapeutics Inc | IKT | 1,750,000 | $3.6M | 3.55% |
| 10 | Allogene Therapeutics Inc | ALLO | 2,546,129 | $3.5M | 3.45% |
| 11 | LeonaBio Inc | 04746L203 | 393,701 | $3.0M | 2.95% |
| 12 | MoonLake Immunotherapeutics | MLTX | 175,734 | $2.3M | 2.29% |
| 13 | Oric Pharmaceuticals Inc | ORIC | 267,059 | $2.2M | 2.16% |
| 14 | Verrica Pharmaceuticals Inc | VRCA | 235,779 | $2.0M | 1.94% |
| 15 | Tyra Biosciences Inc | TYRA | 74,465 | $2.0M | 1.94% |
| 16 | Surrozen Inc | SRZNW | 385,178 | $1.9M | 1.87% |
| 17 | Tenaya Therapeutics Inc | TNYA | 2,000,000 | $1.4M | 1.41% |
| 18 | Kalaris Therapeutics Inc | KLRS | 139,901 | $1.2M | 1.17% |
| 19 | Diamedica Therapeutics Inc | DMAC | 95,359 | $759,058 | 0.75% |